Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Glucagon market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Glucagon market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Glucagon market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Glucagon products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Glucagon products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Glucagon market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Glucagon development has been the leading industry trend of Glucagon market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Glucagon Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Exenatied,Liraglutide,Lixisenatide,Albiglutide,Dulaglutide |
| By Application Outlook |
Hospital,Pharmacy,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Novo Nordisk,AstraZeneca,Eli Lilly,GSK,Sanofi,Bristol-Myers Squibb,Amylin |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Novo Nordisk
- AstraZeneca
- Eli Lilly
- GSK
- Sanofi
- Bristol-Myers Squibb
- Amylin
Glucagon Market, By Type
- Exenatied
- Liraglutide
- Lixisenatide
- Albiglutide
- Dulaglutide
Glucagon Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Glucagon Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Glucagon Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Glucagon Industry Overview
2.1 Global Glucagon Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Glucagon Global Import Market Analysis
2.1.2 Glucagon Global Export Market Analysis
2.1.3 Glucagon Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Exenatied
2.2.2 Liraglutide
2.2.3 Lixisenatide
2.2.4 Albiglutide
2.2.5 Dulaglutide
2.3.2 Pharmacy
2.3.3 Other
2.4.2 Global Glucagon Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Glucagon Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Glucagon Manufacturer Market Share
2.4.5 Top 10 Glucagon Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Glucagon Market
2.4.7 Key Manufacturers Glucagon Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Glucagon Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Glucagon Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Glucagon Market Size Categorized by Regions
4.1 Global Glucagon Revenue, Sales and Market Share by Regions
4.1.1 Global Glucagon Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glucagon Revenue and Market Share by Regions (2015-2020)
4.2 Europe Glucagon Sales and Growth Rate (2015-2020)
4.3 APAC Glucagon Sales and Growth Rate (2015-2020)
4.4 North America Glucagon Sales and Growth Rate (2015-2020)
4.5 South America Glucagon Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Glucagon Sales and Growth Rate (2015-2020)
5 Europe Glucagon Market Size Categorized by Countries
5.1 Europe Glucagon Sales, Revenue and Market Share by Countries
5.1.1 Europe Glucagon Sales by Countries (2015-2020)
5.1.2 Europe Glucagon Revenue by Countries (2015-2020)
5.1.3 Germany Glucagon Sales and Growth Rate (2015-2020)
5.1.4 UK Glucagon Sales and Growth Rate (2015-2020)
5.1.5 France Glucagon Sales and Growth Rate (2015-2020)
5.1.6 Russia Glucagon Sales and Growth Rate (2015-2020)
5.1.7 Italy Glucagon Sales and Growth Rate (2015-2020)
5.1.8 Spain Glucagon Sales and Growth Rate (2015-2020)
5.2 Europe Glucagon Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Glucagon Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Glucagon Sales Market Share by Type (2015-2020)
5.3.2 Europe Glucagon Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Glucagon Sales Market Share by Application (2015-2020)
6 Asia-Pacific Glucagon Market Size Categorized by Countries
6.1 Asia-Pacific Glucagon Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Glucagon Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Glucagon Revenue by Countries (2015-2020)
6.1.3 China Glucagon Sales and Growth Rate (2015-2020)
6.1.4 Japan Glucagon Sales and Growth Rate (2015-2020)
6.1.5 Korea Glucagon Sales and Growth Rate (2015-2020)
6.1.6 India Glucagon Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Glucagon Sales and Growth Rate (2015-2020)
6.1.8 Australia Glucagon Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Glucagon Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Glucagon Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Glucagon Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Glucagon Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Glucagon Sales and Market Share by Application (2015-2020)
7 North America Glucagon Market Size Categorized by Countries
7.1 North America Glucagon Sales, Revenue and Market Share by Countries
7.1.1 North America Glucagon Sales by Countries (2015-2020)
7.1.2 North America Glucagon Revenue by Countries (2015-2020)
7.1.3 United States Glucagon Sales and Growth Rate (2015-2020)
7.1.4 Canada Glucagon Sales and Growth Rate (2015-2020)
7.1.5 Mexico Glucagon Sales and Growth Rate (2015-2020)
7.2 North America Glucagon Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Glucagon Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Glucagon Sales Market Share by Type (2015-2020)
7.3.2 North America Glucagon Revenue and Revenue Share by Type (2015-2020)
7.4 North America Glucagon Sales Market Share by Application (2015-2020)
8 South America Glucagon Market Size Categorized by Countries
8.1 South America Glucagon Sales, Revenue and Market Share by Countries
8.1.1 South America Glucagon Sales by Countries (2015-2020)
8.1.2 South America Glucagon Revenue by Countries (2015-2020)
8.1.3 Brazil Glucagon Sales and Growth Rate (2015-2020)
8.2 South America Glucagon Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Glucagon Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Glucagon Sales Market Share by Type (2015-2020)
8.3.2 South America Glucagon Revenue and Revenue Share by Type (2015-2020)
8.4 South America Glucagon Sales Market Share by Application (2015-2020)
9 Middle East and Africa Glucagon Market Size Categorized by Countries
9.1 Middle East and Africa Glucagon Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Glucagon Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Glucagon Revenue by Countries (2015-2020)
9.1.3 GCC Countries Glucagon Sales and Growth Rate (2015-2020)
9.1.4 Turkey Glucagon Sales and Growth Rate (2015-2020)
9.1.5 Egypt Glucagon Sales and Growth Rate (2015-2020)
9.1.6 South Africa Glucagon Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Glucagon Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Glucagon Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Glucagon Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Glucagon Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Glucagon Sales Market Share by Application (2015-2020)
10 Global Glucagon Market Segment by Type
10.1 Global Glucagon Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Glucagon Sales and Market Share by Type (2015-2020)
10.1.2 Global Glucagon Revenue and Market Share by Type (2015-2020)
10.2 Exenatied Sales Growth Rate and Price
10.2.1 Global Exenatied Sales Growth Rate (2015-2020)
10.2.2 Global Exenatied Price (2015-2020)
10.3 Liraglutide Sales Growth Rate and Price
10.3.1 Global Liraglutide Sales Growth Rate (2015-2020)
10.3.2 Global Liraglutide Price (2015-2020)
10.4 Lixisenatide Sales Growth Rate and Price
10.4.1 Global Lixisenatide Sales Growth Rate (2015-2020)
10.4.2 Global Lixisenatide Price (2015-2020)
10.5 Albiglutide Sales Growth Rate and Price
10.5.1 Global Albiglutide Sales Growth Rate (2015-2020)
10.5.2 Global Albiglutide Price (2015-2020)
10.6 Dulaglutide Sales Growth Rate and Price
10.6.1 Global Dulaglutide Sales Growth Rate (2015-2020)
10.6.2 Global Dulaglutide Price (2015-2020)
11.1 Global GlucagonSales Market Share by Application (2015-2020)
11.2 Hospital Sales Growth Rate (2015-2020)
11.3 Pharmacy Sales Growth Rate (2015-2020)
11.4 Other Sales Growth Rate (2015-2020)
12.1 Global Glucagon Revenue, Sales and Growth Rate (2020-2027)
12.2 Glucagon Market Forecast by Regions (2020-2027)
12.2.1 Europe Glucagon Market Forecast (2020-2027)
12.2.2 APAC Glucagon Market Forecast (2020-2027)
12.2.3 North America Glucagon Market Forecast (2020-2027)
12.2.4 South America Glucagon Market Forecast (2020-2027)
12.2.5 Middle East & Africa Glucagon Market Forecast (2020-2027)
12.3 Glucagon Market Forecast by Type (2020-2027)
12.3.1 Global Glucagon Sales Forecast by Type (2020-2027)
12.3.2 Global Glucagon Market Share Forecast by Type (2020-2027)
12.4 Glucagon Market Forecast by Application (2020-2027)
12.4.1 Global Glucagon Sales Forecast by Application (2020-2027)
12.4.2 Global Glucagon Market Share Forecast by Application (2020-2027)
13 Analysis of Glucagon Industry Key Manufacturers
13.1 Novo Nordisk
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Novo Nordisk Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Novo Nordisk News
13.2 AstraZeneca
13.2.1 Company Details
13.2.2 Product Information
13.2.3 AstraZeneca Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 AstraZeneca News
13.3 Eli Lilly
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Eli Lilly Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Eli Lilly News
13.4 GSK
13.4.1 Company Details
13.4.2 Product Information
13.4.3 GSK Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 GSK News
13.5 Sanofi
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Sanofi Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Sanofi News
13.6 Bristol-Myers Squibb
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Bristol-Myers Squibb Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Bristol-Myers Squibb News
13.7 Amylin
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Amylin Glucagon Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Amylin News
15 Appendix
